Biopharma firm AbbVie opens S$400m biologics plant in Tuas
The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs
Singapore
GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.
On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)
TRENDING NOW
From hawker stall to Enterprise Award winner: How Han Keen Juan scaled the Old Chang Kee empire
Haidilao co-founder’s family buys second bungalow in Cluny Hill for S$85 million
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
Ban on land sales, new launches for developers that deliver ‘defect-ridden’ projects